Here are relevant reports on : cardiac-monitoring-market
-
Ultrasound Market by Diagnostic Ultrasound (2D, 3D, 4D, Doppler), Therapeutic Ultrasound (HIFU, ESWL), Products (Cart/Trolley-Based, Compact), Applications (OB/GYN, Cardiac Ultrasound, Vascular Ultrasound, Surgical Ultrasound) - Global Forecast to 2019
The global ultrasound market is estimated to grow at a CAGR of 5.1% in the forecast period. Development of technologically advanced ultrasound devices, rapid growth in aging population with high risk of target diseases, growing demand for minimally invasive treatment procedures, and increasing public-private investments are key factors fuelling the growth of the ultrasound market.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Lateral Flow Assay Components Market by Type (Membrane, Pad), Application (Clinical Testing (Infectious, Cardiac Marker Test, Fertility, Pregnancy, Cholesterol Testing), Veterinary, Food Safety), Technique, End User & Region - Global Forecast to 2030
The global lateral flow assay components market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is projected to advance at a resilient CAGR of 4.4% from 2025 to 2030, culminating in a forecasted valuation of US$486.2 million by the end of the period. Market growth is driven by increasing health awareness and the shift toward lifestyle and home-based healthcare, as more consumers adopt self-monitoring and rapid testing solutions.
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Asia-Pacific Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) – Forecast to 2017
The market is broadly classified into two segments, namely, diagnostic and therapeutic; the former dominated with about 80.7% share in 2012. Radioisotopes in the diagnostic market are categorized as SPECT and PET. Technetium 99m (Tc-99m) dominated the SPECT radioisotope market in 2012, followed by thallium–201(Tl-201), gallium–67 (Ga-67), and iodine-123 (I-123). SPECT is majorly used in cardiology-related diagnosis; it is poised to grow at a CAGR of 10.2% from 2012 to 2017. The radiopharmaceuticals market in the Asia-Pacific region was valued at $500.8 million in 2012; it is poised to reach $824.9million in 2017 at a CAGR of 10.5%.
- Published: May 2013
- Price: $ 4950
- TOC Available:
-
Portable Medical Devices Market; By Equipment (Cardiac, Respiratory, Hemodynamic, Fitness & Wellness, Independent Ageing, Insulin pumps, Ultrasound), Semiconductor Components (Memory, PMIC, Processor, Display, Sensor, Connectivity) (2013 – 2018)
There has been an increasing focus on bringing in wireless communication capabilities into the healthcare industry with the evident advantages associated with wireless technologies. This trend has resulted in more and more portable medical devices being integrated with various wireless technologies like Wi-Fi, Bluetooth, ANT+ and ZigBee. These devices that are portable and have wireless capabilities are referred to as mobile medical devices. Measuring and monitoring applications in healthcare has become much more convenient with display or representation of the data on a mobile computing device, typically a smart-phone or a tablet.
- Published: June 2013
- Price: $ 4950
- TOC Available:
-
Catheters Market by Type (Cardiovascular (Electrophysiology, Coronary Balloon, IVUS/OCT), Intravenous (CVC, PIVC, Midline), Urological, Neurovascular), Indication (Cardiac, Vascular, Kidney, Blood Transfusion, IV Medication Delivery and Fluid Management) - Global Forecast to 2030
The global catheters market, valued at US$28.51 billion in 2024, stood at US$30.53 billion in 2025 and is projected to advance at a resilient CAGR of 8.5% from 2025 to 2030, culminating in a forecasted valuation of US$45.99 billion by the end of the period.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
Defibrillator Market by Product (Implantable Cardioverter Defibrillator, External Defibrillator (Automated Defibrillator, Wearable Defibrillator, Manual Defibrillator)), End User (Hospitals & Clinics, Cardiac Centers, Homecare) - Global Forecast to 2030
The global defibrillator market, valued at US$11.29 billion in 2024, stood at US$11.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$16.44 billion by the end of the period. Major players in the defibrillator market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea).
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Ablation Technologies Market (2011-2016) - (Cancer/tumor, Cardiac, Gynecology, Orthopedics, Radiofrequency, Cryoablation, Microwave, Hydrothermal, Radiation and Laser/ Light) - Global Trends & Competitive Analysis
The global ablation technologies market consists of thermal and non- thermal ablation technologies. Under thermal ablation technologies, radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies are included, whereas non-thermal ablation technologies include cryoablation and hydromechanical. Ablation technologies have applications in various clinical areas such as cancer, cardiac, ophthalmology, urology, gynecology and orthopedics.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Active Implantable Medical Devices Market by Product (Implantable Cardioverter Defibrillators (Transvenous & Subcutaneous), Cardiac Pacemaker, Ventricular Assist Device, Neurostimulator, Implantable Hearing Devices) - Global Forecast to 2022
The active implantable medical devices market is expected to witness significant growth in the coming years. The growing aging population, increasing prevalence of cardiovascular and neurological diseases, investments and funds to develop technologically advanced products, expanded applications of neurostimulators, and favorable reimbursement scenario for ENT procedures in developed countries are some of the factors driving the growth of this market. The implantable and life-sustaining devices market is projected to reach USD 26.75 Billion by 2022 from 18.42 Billion in 2017, at a CAGR of 7.8% from 2017 to 2022.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Ambulance Equipment Market by Type (Transportation, Burn Care, Diagnostic and Infection Control, Blood and Hemorrhage Control, Respiratory, Hypothermia, Cardiac Equipment), by End User (Air Ambulance, Water Ambulance, Ground Ambulance) - Forecast to 2023
The global ambulance equipment market was valued at USD 4.31 Billion in 2017, and is expected to witness a CAGR of 3.3% over the forecast period (2018 – 2026). Ambulance equipment is a type of equipment used to aid patients at the time of medical emergencies, including accidents and surgeries, thus helping minimize personal injuries and preventing loss of life. Advancements in healthcare technology along with increasing patient inclination towards faster and efficient mode of delivery are some of the major factors driving the growth of the global ambulance equipment market. Rising number of emergency cases is another major factor that is expected to enhance growth of the ambulance equipment market during the forecast period.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecasts to 2024
The global cardiac mapping market in terms of revenue was estimated to be worth $1.4 billion in 2019 and is poised to reach $2.1 billion by 2024, growing at a CAGR of 8.7% from 2019 to 2024. The major vendors in the market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US). These leading players offer a strong suit of products for cardiac mapping and have a broad geographic presence. The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).
- Published: January 2020
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
